The Effects of Radium-223 Dichloride Therapy on Radionuclide Bone Scan Lesions.
Condition: Bony Metastases From Castrate Refractory Prostate Cancer Intervention: Drug: Radium-223 dichloride Sponsor: The University of Texas Health Science Center, Houston Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | PET Scan | Prostate Cancer | Research | Science | Texas University